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Abstract
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited pro-
gressive cardiomyopathy, clinically characterized by ventricular arrhythmias and increased 
risk of sudden cardiac death. Echocardiography has a role in the diagnosis and prognosis of 
ARVD/C. However, in the current era of magnetic resonance imaging (MRI), the role of echo-
cardiography in ARVD/C patients and family member screening is subject to debate. Relatively 
novel echocardiographic techniques, such as three-dimensional right ventricular (3D-RV) 
imaging and tissue deformation imaging, may improve the diagnostic and prognostic perfor-
mance of echocardiography in these patients.
3D-RV imaging provides more insights on RV anatomy and global function compared to con-
ventional echocardiography. Subtle RV regional wall motion abnormalities, and mechanical 
dyssynchrony, are accurately measured by tissue deformation imaging.
Several studies suggest an incremental value of novel echocardiographic parameters in addi-
tion to conventional measurements. Moreover, new parameters indicating subtle RV dysfunc-
tion, and mechanical dyssynchrony, are of predictive value and could help in risk stratification 
of ARVD/C patients.
New robust parameters, derived from 3D-RV echocardiography and RV tissue deformation 
imaging, in combination with established conventional parameters, suggest that there is a cur-
rent and future role for echocardiography in ARVD/C supplementing MRI. (Cardiol J 2015; 
22, 4: 362–374)
Key words: ARVD/C, echocardiography, tissue deformation imaging, three- 
-dimensional echocardiography, prognosis, diagnosis
Editorial p. 355
Introduction
Arrhythmogenic right ventricular dysplasia/ 
/cardiomyopathy (ARVD/C) is an inherited pro-
gressive cardiomyopathy, clinically characterized 
by life-threatening ventricular arrhythmias and, 
in advanced stages, heart failure [1]. In up to 60% 
of ARVD/C patients, genetic mutations are found 
in genes encoding for desmosomal proteins [2, 3]. 
Desmosomes are located in the intercalated disc 
and provide structural and functional integrity 
between cardiac myocytes [4]. Desmosomal dys-
function leads to both mechanical and electrical 
uncoupling [4, 5]. This mechanical uncoupling is 
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associated with fibro-fatty replacement of the myo-
cardium and right ventricular (RV) dysfunction [6]. 
Electrical uncoupling of cardiac myocytes and the 
presence of surviving myocardial bundles within 
the fibrofatty tissue promote activation delay, 
therefore providing a substrate (macro re-entry) 
for ventricular arrhythmias [5, 7].
In Europe and North America, desmosomal 
mutations are predominantly found in the plakophi-
lin-2 (PKP2) gene [3, 8, 9]. However, pathogenic 
ARVD/C mutations show incomplete penetrance 
and wide variable phenotypic expression [3]. 
Therefore, risk stratification remains challenging. 
Although desmosomes are expressed in all cardiac 
myocytes, a typical distribution of disease expres-
sion is observed. Typical involved areas are the 
subtricuspid region, the right ventricular outflow 
tract (RVOT), and the left ventricular (LV) poste-
rolateral wall [10]. Traditionally, the RV apex was 
seen as an important region which was involved 
in this disease and was included in the so called 
“triangle of dysplasia” [1]. However, recent stud-
ies have shown that the RV apex is only involved 
in advanced stages of the disease [10]. Secondly, 
LV involvement is more common than previously 
thought, with a clear predilection site in the LV 
posterolateral region (Fig. 1) [10, 11].
ARVD/C is diagnosed according to major and 
minor criteria stated in the 2010 revised Task Force 
criteria (TFC) [12]. The 2010 TFC include different 
categories: (1) structural RV alterations, (2) tissue 
characterization, (3) depolarization and repolariza-
tion abnormalities, (4) ventricular arrhythmias, 
and (5) family history and genetic data [12]. The 
diagnostic criteria are fulfilled by the presence of 
2 major, or 1 major plus 2 minor criteria or 4 minor 
criteria from different groups. RV functional and 
structural alterations are visualized by using differ-
ent imaging modalities such as echocardiography, 
magnetic resonance imaging (MRI), and angio-
graphy. Diagnostic imaging criteria are scored if 
a regional RV wall motion abnormality is present in 
combination with RV dilatation or global RV systolic 
dysfunction [12]. Modality-specific cut-off values 
concerning global RV dysfunction and RV dilatation 
are provided in the 2010 TFC (Table 1) [12].
Echocardiography is a noninvasive, and widely 
available imaging tool to evaluate patients with 
known or suspected ARVD/C. However, complete 
and accurate RV echocardiography is difficult due 
to the retrosternal position and complex geometry 
of the RV. MRI is not hampered by these limita-
tions and has therefore taken a prominent role in 
imaging for ARVD/C [13]. Recently, MRI was found 
to be of superior value for the diagnosis of ARVC 
compared to conventional echocardiography [14]. 
Nevertheless, MRI is also prone to false-positive 
findings if there is an overreliance on detection 
of intramyocardial fat and wall thinning [15]. In 
addition, determination of normal RV wall motion 
Figure 1. Triangle of dysplasia. A. Original triangle of dysplasia consisting of the following regions: 1) subtricuspid 
region, 2) right ventricular outflow tract (RVOT), and 3) apical region; B. Revised triangle of dysplasia. The left ventricu-
lar (LV) posterolateral wall seems to be a clear predilection site of arrhythmogenic right ventricular dysplasia/cardio- 
myopathy and is more commonly involved compared to the apical region.
A B
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around the moderator band insertions remains 
difficult by MRI [15, 16].
Emerging new echocardiographic techniques, 
specifically three dimensional (3D) RV echocar-
diography and tissue deformation imaging, may 
increase the performance of echocardiography, 
overcoming the previously mentioned shortcom-
ing of conventional RV echocardiography [17, 18]. 
3D imaging enables more accurate RV volumetric 
measurements compared to conventional echo-
cardiography [19, 20]. Regional deformation imag-
ing, another relatively new technique, quantifies 
regional RV wall motion and provides timing of 
regional motion [18, 21].
Implantable cardioverter-defibrillators (ICD) 
are frequently implanted in ARVD/C patients to 
prevent sudden arrhythmic death. These metallic 
devices make MRI unsuitable for evaluation of 
ARVD/C patients. For the purpose of monitoring 
ARVD/C patients, echocardiography is the current 
preferred imaging technology [22]. Novel echocar-
diographic techniques could conceivably provide 
new predictors for the occurrence of cardiac events 
during follow-up in addition to conventional meas-
ures of RV and LV function.
In this review, we aim to evaluate the cur-
rent and future role of both conventional and new 
echocardiographic parameters in ARVD/C with 
respect to the diagnosis of the disease as well 
as follow-up. We provide illustrative examples 
of this relatively rare disease entity and we have 
added our echocardiographic protocol as a guide 
for the clinician.
Conventional echocardiography
Extensive fibrofatty replacement of the myo-
cardium affects regional ventricular wall motion 
and global systolic function [1]. Impaired systolic 
function leads to structural RV remodeling and is 
detected by conventional echocardiography as both 
global RV dilatation and RV systolic dysfunction 
[23, 24].
Regional and global RV dilatation are well 
described phenotypic features in ARVD/C pa-
tients [24]. RV inflow tract, RVOT, and longitudi-
nal dimensions have been found to be increased 
compared to healthy controls (Fig. 2) [17, 23–26]. 
Several robust parameters representing RV sys-
tolic function, such as the tricuspid annular plane 
systolic excursion (TAPSE), peak systolic RV 
annular velocity, and RV-fractional area change 
(RV-FAC), provide insight into global RV function 
and are generally decreased in ARVD/C (Fig. 3) 
[17, 23–25, 27]. Altered morphologic appearances, 
e.g. a hyper-reflective moderator band and exces-
sive trabecular derangement, are also reported in 
ARVD/C (Table 2) [24]. However, these findings 
lack specificity and were not included in the 2010 
TFC. A study performed by Yoerger et al. [24] 
in 2005 found that impaired RV-FAC and RVOT 
dilatation were the most common abnormal echo-
cardiographic findings in ARVD/C patients. RVOT 
dilatation in the parasternal long-axis view was pre-
sent in all ARVD/C patients and decreased RV-FAC 
was present in 62% of patients. Eventually, these 
parameters were chosen for the echocardiographic 
2010 TFC [12]. TAPSE and peak systolic RV an-
nular velocity were not evaluated in this study and 
could be the reason why these parameters are not 
part of the 2010 TFC.
Table 1. 2010 Task Force criteria. Global or  
regional dysfunction and structural alterations.
Echocardiography
Regional RV akinesia, dyskinesia, or aneurysm and 
one of the following parameters:
Major
PLAX RVOT ≥ 32 mm or corrected for BSA ≥ 19 mm/m2
PSAX RVOT ≥ 36 mm or corrected for BSA ≥ 21 mm/m2
RV-FAC ≤ 33%
Minor
PLAX RVOT ≥ 29 to < 32 mm or corrected  
for BSA ≥ 16 to < 19 mm/m2
PSAX RVOT ≥ 32 to < 36 mm or corrected  
for BSA ≥ 18 to < 21 mm/m2
RV-FAC > 33% to ≤ 40%
Magnetic resonance imaging
Regional RV akinesia, dyskinesia, or dyssynchronous 
RV contraction
Major
Ratio of RVEDV to BSA ≥ 110 mL/m2 (male)  
or ≥ 100 mL/m2 (female)  
RVEF ≤ 40%
Minor
Ratio of RVEDV to BSA ≥ 100 to < 110 mL/m2 (male) 
or ≥ 90 to < 100 mL/m2 (female)  
RVEF > 40% to ≤ 45%
RV angiography
Major
Regional RV akinesia, dyskinesia, or aneurysm
Minor
No minor criterion is specified for this modality
Derived from the 2010 Task Force criteria; RVOT — right ventricular 
outflow tract; FAC — fractional area change; RV — right ventricle; 
RVEF — right ventricular ejection fraction; RVEDV — right ventricular 
end-diastolic volume; PLAX/PSAX — parasternal long/shorts axis; 
BSA — body surface area
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Figure 2. Conventional echocardiography in an arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) 
patient; Left upper: PLAX, severe RVOT dilatation (57 mm, 27.4 mm/m2) in 57-year-old ARVD/C patient; Right upper: 
RV SAX, apical thrombus in 16-year-old ARVD/C patient, RV-FAC was 29%; Left lower: AP4CH, severe dilatation 
of RV, RVIT = 49 mm, and hyperreflective moderator band; Right lower: AP4CH, apical aneurysm and segmental 
subtricuspid dilatation; PLAX — parasternal long axis view; RVOT — right ventricular outflow tract; RV — right ven-
tricle; SAX — short axis view; RV-FAC — right ventricular-fractional area change; AP4CH — apical 4 chamber view; 
RVIT — right ventricular inflow tract.
Figure 3. Conventional right ventricular measurements. Example of measurements of tricuspid annular plane systolic 
excursion (TAPSE) (upper left), peak annular systolic velocity (upper right), right ventricular outflow tract (RVOT) 
(lower left) and right ventricular-fractional area change (RV-FAC) (lower right).
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Conventional echocardiography is part of the 
current diagnostic 2010 TFC and consists of visual 
regional wall motion analyses, outflow tract di-
mensions and RV-FAC [12]. An echocardiographic 
TFC is assigned if RVOT dilatation or decreased 
RV-FAC is observed in combination with abnormal 
regional wall motion [12]. Akinetic, dyskinetic, or 
aneurysmatic RV wall segments are considered 
abnormal. Importantly, hypokinesis is not a part 
of the 2010 TFC [12]. In a study performed in our 
institution, we found that regional hypokinesia 
is a common finding in healthy individuals [28]. 
Depending on the degree of RVOT dilatation and 
reduction of RV-FAC, a major or minor criterion is 
assessed (Table 1) [12]. The presence of abnormal 
regional wall motion is mandatory for a major or 
minor criterion regardless of RVOT dilatation 
and/or systolic dysfunction. Therefore, optimal 
visual RV wall motion analysis is crucial and we 
suggest that all RV regions should be visualized 
during the examination (Fig. 4) [26, 29]. Contrast 
enhanced echocardiography could be used to im-
prove delineation of the RV free wall and enables 
more accurate RV wall motion analyses where 
there is suboptimal imaging quality [30]. Values 
for echocardiographic TFC were chosen for high 
specificity (76–95%) resulting in reduced sensi-
tivity (55–87%) [12, 14]. Abnormal findings not 
fulfilling the current TFC should either be further 
assessed by MRI or these patients should undergo 
a follow-up echocardiogram after 1 year. This rec-
ommendation is based on our current practice and 
experience since there is currently no literature 
to support it. In addition to the diagnostic role of 
conventional echocardiography in ARVD/C, the 
prognostic value of echocardiography in ARVD/C 
has been extensively explored [22, 31, 32]. Both 
decreased TAPSE and RV-FAC are associated with 
the occurrence of major adverse cardiac events 
in ARVD/C [22, 32]. Both parameters are easily 
obtained and aid risk stratification of ARVD/C 
patients (Fig. 3). Several studies have shown the 
clinical importance of LV involvement in ARVD/C 
[11, 31, 32]. Although, originally considered an 
end-stage phenomenon, LV involvement in a broad 
spectrum of ARVD/C patients has been shown 
[10, 33, 34]. Echocardiographically measured 
reduced LV ejection fraction has been found to be 
the strongest independent predictor of adverse 
outcome [31, 32].
All aforementioned parameters are easily 
obtained by conventional echocardiography and 
provide useful information during diagnostic evalu-
ation and follow-up in ARVD/C. The precise in-
terval of repeated echocardiographic evaluation 
is unknown in patients diagnosed with ARVD/C. 
We advise echocardiographic interrogation in 
patients when clinical changes occur (e.g. heart 
failure, arrhythmias, and syncope). In stable pa-
tients with no change in any clinical parameter, an 
echocardiographic follow up every 4–5 years seems 
reasonable (unpublished data).
We have provided the ARVD/C focused echo-
cardiographic protocol which is currently in use in 
our institution (Fig. 4).
Three-dimensional echocardiography
There is a marked difference between MRI 
and echocardiography in the 2010 TFC with re-
spect to measuring RV dilatation and RV systolic 
dysfunction. Global RV dilatation by MRI is directly 
measured by RV end-diastolic volume (RVEDV), 
whereas conventional echocardiography only uses 
segmental outflow tract dilatation [12]. RVEDV 
and RV end-systolic volume (RVESV) leads to 
a 3D measurement of RV systolic function 
Table 2. Wall motion abnormalities and mor-
phological appearances in arrhythmogenic right 
ventricular dysplasia/cardiomyopathy patients.
Parameters N = 29 [24]
Percent of probands
RV global systolic function
RV-FAC ≥ 32% 38
RV-FAC ≥ 26% to < 32% 28
RV-FAC < 26% 34
RV regional WMA 79
RVOT 45
Anteroseptal 55
Anterior 70
Apex 72
Septal 55
Inferior basal 59
Inferior apical 52
Hyperreflective  
moderator band
31
Excessive/abnormal  
trabeculations
54
Sacculations 17
RV — right ventricle; RV-FAC — right ventricular-fractional area 
change; RVOT — right ventricular outflow tract; WMA — wall  
motion abnormalities
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(ejection fraction) by MRI. Echocardiographic RV 
systolic function only contains a 2D measurement, 
by measuring the amount of RV area decrease 
during systole. This limited approach is due to 
the retrosternal location and complex crescent 
geometry of the RV. Therefore, the simple geo-
metrical assumptions based on 2D acquisition 
that is frequently used in assessing LV dimen-
sions, are invalid for the RV and prevents optimal 
volumetric calculation. These measurements by 
echocardiography are likely inferior to the 3D 
volumetric analysis performed by MRI. However, 
3D-echocardiography is both feasible and compa-
rable to MRI with respect to RV volumes and RV 
ejection fraction (RVEF) (Fig. 5) [19, 20, 35]. With 
the implementation of 3D-echocardiography, subtle 
Clinical data Length, weight, BSA
View Remarks Measurements
Long axis (PLAX) Zoom RVOT RVOT PLAX dimension, RVOT-anterior wall motion 
analyses (green)
RV-2-chamber view RV-anterior (blue) wall motion analyses, RV inferior 
(red) wall motion analyses
Short axis (PSAX) Aortic valve level RVOT PSAX dimension, RVOT-anterior wall motion 
analyses (green)
RV midventricular  
and apical level
RV anterior wall motion analyses (blue), RV lateral 
wall motion analyses (yellow), and RV inferior wall 
motion analyses (red)
4-chamber view RV focused apical position RV lateral wall motion analyses (yellow), RV-FAC, 
TAPSE, RV peak annular velocity
RV inflow-outflow RVOT wall motion analyses (green), RV-anterior  
wall motion analyses (blue), RV- inferior wall  
motion analyses (red)
RV subcostal view RV inferior wall motion analyses (red) 
Protocol is in addition to standard conventional echocardiography as provided by the American Society of echocardiography (ASE);  
BSA — body surface area; PLAX/PSAX — parasternal long/short axis view; RV — right ventricular; RVOT — right ventricular outflow 
tract; RV-FAC — right ventricular-fractional area change; TAPSE — tricuspid annular plane systolic excursion
Figure 4. Echocardiographic arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) protocol and right 
ventricular (RV) view; RA — right atrium; LV — left ventricle; LA — left atrium.
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Figure 5. Perimeters of 3-dimensional-right ventricular (3D-RV) of imaging; A. 3D-RV echocardiographic imaging pro-
viding excellent insight in RV anatomy; B. 3D acquisition with knowledge based reconstruction. Multiple landmarks, 
chosen in 2D images, are used to reconstruct the RV anatomy; PV — pulmonary valve; TV — tricuspid valve.
global RV systolic dysfunction can be seen in the 
early stages of ARVD/C, and can contribute to early 
diagnosis [36]. In ARVD/C patients, Prakasa et al. 
[19] found varying results by 2D-echocardiography 
compared to MRI for RVESV, RVEDV and RVEF 
with Pearson’s correlations of 0.72, 0.50 and 0.88, 
respectively. 3D-echocardiography is hampered 
by acoustic dropout of the RV free wall and the 
anterior RV wall in patients with a dilated RV [19]. 
The current software algorithms may account for 
the frequently observed abnormal RV shape in 
ARVD/C patients with large saccular aneurysms. 
These two mechanisms likely explain the low yield 
of 3D-echocardiography in this subset of patients. 
A possible approach to overcome the limitation 
of acoustic dropout is to use 3D-based RV recon-
struction to obtain RV volumes and function (Fig. 5) 
[37, 38]. The reconstruction technique uses a mag-
netic field generator and a magnetic field sensor 
attached to the transducer to accurately localize 
2D obtained RV anatomic landmarks within the 
magnetic field [37]. The reconstruction algorithm 
uses the distances between RV landmarks to match 
the landmarks to a catalog of subjects with similar 
RV anatomy. This 3D-based technique shows high 
correlation with MRI derived volumetric measure-
ments in patients with pulmonary hypertension and 
congenital heart diseases. Inter-method correlation 
A
B
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was 0.87–1.00 (RVEDV), 0.88–1.00 (RVESV), and 
0.75–0.88 (RVEF) [37, 38]. We currently lack stud-
ies with 3D-based RV reconstruction in ARVD/C 
patients.
Tissue deformation imaging
Echocardiographic tissue deformation imaging 
is a relatively new technique that provides quantita-
tive regional wall motion analysis. Currently, two 
different techniques are commercially available: 
tissue Doppler imaging and speckle-tracking. 
Both techniques rely on different principles to 
calculate both regional and global deformation and 
deformation rate. We have previously shown that 
both techniques are feasible in the RV and that the 
calculated values are comparable to one another in 
ARVD/C patients [18].
Tissue Doppler imaging uses the differences 
between two velocity-time curves to measure the 
regional deformation of the myocardium. Velocity-
time curves are derived from two points of known 
distance and encompass a region of interest. De-
formation of the region of interest is absent if the 
difference between two velocity-time curves is 
zero, indicating this net resultant force on the myo-
cardium is zero. However, differences in velocity-
time curves indicate deformation, i.e. shortening 
or lengthening, of the myocardium. Deformation 
is plotted against time in a strain-time curve over 
the cardiac cycle (Fig. 6).
Speckle tracking (or 2D-strain) uses natural 
acoustic echocardiographic reflection (speckles) in 
the B-mode image made within the myocardium 
to measure deformation. This speckle pattern 
is unique for each myocardial region and it is 
Figure 6. Tissue deformation imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C); Left 
upper: Tissue deformation imaging by speckle tracking. In the apical 4 chamber view the right ventricular (RV) lateral 
wall is traced and divided into the basal (red), mid (blue), and apical view (pink); Right upper: Normal RV deformation 
patterns with shortening during systole and stretching in diastole. All systolic strain values are approximately –30%. 
Cut off value is –18% to differentiate between normal and abnormal peak systolic strain; Left lower: RV deformation 
pattern in an ARVD/C relative. The apical (pink) and mid segment (blue) shows normal deformation. However, the 
basal (red) curve showed marked prestretch, delayed onset of shortening, and post-systolic shortening. In this patient, 
abnormal subtricuspid deformation was seen in absence of structural abnormalities according to the 2010 revised 
Task Force criteria; Right lower: RV deformation pattern in an ARVD/C patient. The apical segment (pink) shows 
normal deformation. Mid segment shows lower values of systolic peak strain (< –18%) and post-systolic shortening. 
The basal segment shows a dyskinetic pattern with stretching during systole; LV — left ventricular; RA — right atrium.
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relatively stable throughout the cardiac cycle. The 
displacement of this speckled pattern is considered 
to follow myocardial movement and the change be-
tween speckles represents myocardial deformation. 
With dedicated software, it is possible to accurately 
track these speckle patterns throughout the cardiac 
cycle. The resulting data provide both regional and 
global deformation (rate) in the longitudinal direc-
tion. Radial strain in the thin walled RV is unreliable 
and we do not recommend its use in the RV [18, 39]. 
An in depth review on image acquisition, post pro-
cessing, interpretation and implementation of both 
techniques has been published [18].
Due to the longitudinal fiber orientation of the 
RV cardiomyocytes, the resulting RV systolic wall 
motion is predominantly longitudinal [40]. Thus, 
the base of the ventricle (annular plane) moves 
apically, while the active inward motion is minimal 
and predominantly a result of tethering/traction at 
the LV insertion sites [41]. Consequently, RV myo-
cardial tissue deformation results in longitudinal 
systolic shortening (Fig. 5). The RV lateral free 
wall recordings, acquired in the apical 4 chamber 
view, are feasible for deformation imaging (> 90%) 
in ARVD/C patients [17, 42, 43]. Limitations in 
temporal resolution and angle dependency ex-
clude the anterior, inferior, and RVOT for optimal 
deformation imaging analysis. However, Greiner 
et al. [43] explored multi-plane strain imaging to 
assess the antero- and infero-lateral side of the RV 
free wall and reported a high feasibility (84%). The 
role of 3D-speckle tracking has been investigated 
by Atsumi et al. [44]. 3D-speckle tracking records 
endocardial surface changes during the cardiac 
cycle and may provide more information than 2D 
longitudinal deformation. Both multiplane- and 
3D-speckle measurement of tracking are promis-
ing new applications in RV deformation imaging. 
However, further validation is needed before 
recommendations for clinical implementations 
can be made.
A major advantage of tissue deformation imag-
ing compared to conventional echocardiographic 
wall motion analysis, is the ability to quantify 
regional wall motion rather than visual qualitative 
assessment. Quantifying wall motion facilitates the 
detection of subtle regional myocardial dysfunction. 
However, deformation imaging analysis is not ham-
pered by visual misinterpretation of wall motion 
caused by tissue tethering. A third advantage is the 
ability to compare different myocardial segments 
over time to measure mechanical synchrony.
Systolic deformation
In this section, we provide the current pub-
lished applications in deformation imaging.
As previously mentioned, fibrofatty replace-
ment of the myocardium subsequently impairs wall 
motion at specific sites in the RV. This is reflected by 
a reduced amount of peak systolic strain in the RV 
free wall in ARVD/C patients compared to controls 
(Fig. 6) [20, 36, 45]. Peak systolic strain seems to 
be a reliable measurement of impaired wall motion 
and has high diagnostic value [17, 20, 42, 46, 47]. 
Moreover, deformation imaging reveals subtle 
wall motion abnormalities often in the absence 
of RV dilatation, global RV systolic function, and 
visual wall motion abnormalities [17]. Therefore, 
diagnostic performance of peak systolic strain was 
found to be superior to conventional measurements 
in ARVD/C patients [17, 42, 47]. A cut-off value of 
–18% peak systolic strain, to differentiate between 
normal and abnormal RV segments, seems to be 
a reliable parameter and was reported by Prakasa 
et al. [47]. Diagnostic performance was measured 
by Teske et al. [17] who found sensitivity of 97% 
and a specificity of 91%. Implementations of these 
findings (systolic peak strain and the presence of 
post-systolic shortening, in asymptomatic ARVD/C 
mutation carriers showed abnormalities in 71% of 
patients even though imaging criteria were not met 
by the 2010 TFC) [28]. While these measurements 
are very sensitive to detect regional contractility 
abnormalities, they lack specificity since other 
disease processes affecting the myocardium (is-
chemia, sarcoidosis, etc.) also produce a reduction 
of deformation parameters.
Beside regional wall motion analysis, deforma-
tion imaging also provides accurate measurements 
of global systolic RV function. In a (partial) ARVD/C 
cohort, mean RV free wall peak strain showed the 
strongest correlation with MRI obtained RVEF 
compared to other conventional 2D systolic param-
eters [48]. Several studies suggest an important 
role of exercise in the pathogenesis of ARVD/C 
[49, 50]. Extensive exercise seems to accelerate 
the course of disease. Acute effect of exercise on 
cardiac function was explored with stress echo-
cardiography by Vitarelli et al. [42]. The normal 
increase in both RV and LV global longitudinal 
shortening was reduced after exercise in ARVD/C 
patients compared to controls. This is most likely 
explained by the fact that higher loading conditions 
in the RV during exercise unmask abnormal seg-
ments that have normal function in the normal (low 
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pressure – low volume) resting situation. Diagnostic 
performance of these parameters exceeded both 
conventional measurements and regional longitudinal 
strain parameters. Both sensitivity and specificity 
were reported as greater than 90% [42].
Deformation after pulmonary valve closure
Post-systolic shortening (PSS) is an additional 
deformation imaging-derived parameter frequently 
detected in ARVD/C [28]. PSS is defined as the 
presence of longitudinal shortening after semilunar 
valve closure (i.e. pulmonary valve) [51]. It is 
a well described phenomenon in both ischemic- and 
non-ischemic cardiomyopathies [51–53]. The exact 
mechanism of PSS is unclear. In a dyskinetic seg-
ment, PSS may originate as passive recoil by tissue 
interaction with surrounding contracting segments 
[45]. PSS could also be explained by local differ-
ences in electro-mechanical delay resulting in an 
out of phase active contraction [53]. Post-systolic 
shortening was found in 77.4% of the ARVD/C 
patients in the subtricuspid area [17]. Moreover, 
post-systolic shortening is proven to be an early 
sign of disease in asymptomatic PKP2 mutation 
carriers (64%) without an established phenotypic 
expression of disease and could be of value in di-
agnosing ARVD/C (Fig. 6) [28].
Dispersion of timing
Evidence is accumulating that electrical 
abnormalities precede structural alterations in 
ARVD/C [5, 54]. Consequently, early phenotypic 
expressions of ARVD/C would likely be of elec-
trical-rather than structural origin. Due to the 
electro-mechanical contraction coupling, delay in 
myocardial electrical activation could be studied by 
mechanical activation patterns [55–57]. The high 
temporal resolution of echocardiography makes 
deformation imaging a suitable tool for measuring 
mechanical dyssynchrony. Measurements of dys-
synchrony could provide evidence of early, subtle 
electrical disturbances in ARVD/C, and may further 
improve the diagnostic value of echocardiography 
[21, 58]. Moreover, due to the close relationship 
with electrical dyssynchrony, or electrical activa-
tion delay, mechanical dyssynchrony also contains 
possible prognostic information in predicting future 
arrhythmic events [21].
RV mechanical dyssynchrony in ARVD/C 
patients was first described by measuring time to 
peak velocity [58]. Tops et al. [58] showed marked 
delay in timing of septal and RV free wall peak ve-
locity in ARVD/C compared to controls, indicating 
RV mechanical delay. Regional time to systolic peak 
data was analyzed by Sarvari et al.[21] and showed 
that dispersion of time to peak systolic value within 
the RV was markedly increased in ARVD/C patients 
compared to controls. They also found this effect in 
asymptomatic ARVD/C mutation carriers not fulfill-
ing 2010 TFC, indicating early diagnostic value of 
mechanical dyssynchrony. Increased mechanical 
dispersion, probably due to the close correlation 
with electrical dyssynchrony, was also correlated 
with the occurrence of ventricular arrhythmias in 
ARVD/C patients [21].
Discussion
Echocardiography is a non-invasive imaging 
tool that has an established role in both diagnosis 
and prognosis of ARVD/C patients [12, 24]. Early 
and accurate diagnosis of ARVD/C is pivotal, since 
lethal ventricular arrhythmias may occur in the 
very early stages of ARVD/C before overt struc-
tural alterations appear [59]. The current 2010 TFC 
echocardiographic measurements are not consid-
ered equally reliable as MRI based measurements 
[14]. Specifically, the difficult detection of regional 
wall abnormalities results in low sensitivity of 
echocardiography [14]. Several groups have shown 
the incremental diagnostic value of new echocar-
diographic tools such as 3D-echocardiography and 
tissue deformation imaging, and this could change 
the diagnostic role of echocardiography in ARVD/C.
Recent advances in 3D-echocardiography could 
improve assessment of RV volume and RV function 
and may prevent false-negative findings if performed 
together with other established conventional echo-
cardiographic parameters [36]. Adding tissue defor-
mation imaging derived parameters, especially peak 
systolic strain, could increase the yield of ARVD/C 
echocardiographic TFC [17, 20, 36, 46].
Recent insights into the pathophysiology of 
ARVD/C emphasize the importance of further 
exploring the parameters of mechanical dyssyn-
chrony [5, 54]. Mechanical activation parameters 
derived from tissue deformation imaging could be 
of incremental value, especially the early detection 
of ARVD/C [55–57].
Risk stratification in ARVD/C mutation car-
riers is hampered by the large variability of both 
penetrance and disease severity (phenotypic ex-
pression) during the course of the disease. MRI 
is often not feasible for the periodical follow-up 
of ARVD/C patients due to the high rate of ICD 
implantation and the relative high cost. Thus, 
identifying reliable echocardiographic predictors 
in both early and advanced stages of disease is of 
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utmost importance. Prognostic echocardiographic 
factors are already established in the more advanced 
disease stages [22, 32]. Both echocardiographic 
measured RV dysfunction and LV systolic dysfunc-
tion are known predictors for adverse outcome in 
ARVD/C [19, 31, 27]. However, life-threatening ar-
rhythmic events may occur before extensive global 
systolic dysfunction. Future studies should focus on 
the correlation of subtle regional dysfunction and 
dyssynchrony with cardiac events [21, 59]. A study 
on the comparison between deformation imaging 
derived regional abnormalities and electrical abnor-
malities found during an electrophysiological study 
has to be performed to validate the current findings 
in electromechanical dyssynchrony. Validation is of 
particular importance since a recent study showed 
a weak correlation between late gadolinium contrast 
enhanced regions by MRI and the electro-anatomical 
scar a by electrophysiological study [60].
Finally, subtle changes in volumes and func-
tion over time could also have incremental value in 
predicting cardiac events compared to conventional 
measurements.
Conclusions
Conventional echocardiography has an estab-
lished role in diagnosis and prognosis of ARVD/C. 
Novel echocardiographic parameters, derived from 
3D-RV echocardiography and RV tissue deforma-
tion imaging, are promising to improve diagnostic 
sensitivity and specificity. Further validation is 
mandatory. Nevertheless, new echocardiographic 
parameters, combined with conventional parame-
ters, enhances detection of phenotypic expressions 
of ARVD/C and indicates that there is a current 
and future role for echocardiography in ARVD/C.
In the ARVD/C patient, both echocardiogra-
phy and MRI will remain complementary imaging 
modalities in the near future. Novel validated echo-
cardiographic parameters will have the capability to 
detect subtle regional changes for the purpose of 
early diagnosis in absence of global RV structural 
alterations. Serial echocardiographic examination 
will provide insight in the progression of ARVD/C. 
Identification of robust predictors of adverse clini-
cal outcome will guide therapeutic strategies and 
may prevent life threatening events.
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